Dextran Hydrogel Microparticles for Stable Cell Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing hydrogel microbeads face challenges in achieving high yield, biocompatibility, stability, and controlled cell encapsulation, with issues such as cell settling, bead instability, and rapid degradation, limiting their use in standard laboratory techniques and complex analyses like FACS and immunofluorescence.
Innovation Solution
The use of modified dextran hydrogel microparticles, comprising vinyl sulfone functionalized dextran and a crosslinkable polymer with thiol functions, produced through microfluidic technology, allows for stable cell encapsulation and controlled polymerization, enabling prolonged cell culture and modifiable stiffness for various applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If thiol-maleimide chemistry is used for crosslinking, then cell encapsulation is achieved, but bead stability deteriorates due to rapid degradation within 3-21 days
Solution Approach 1:
The patent changes the chemical parameters of the crosslinking system by replacing thiol-maleimide chemistry with vinyl sulfone-thiol chemistry. This parameter change transforms the degradation timeline from days (3-21 days) to weeks (2-4 weeks), achieving both cell encapsulation and extended bead stability required for prolonged cell culture applications.
Solution Approach 2:
The patent uses a composite crosslinking system combining vinyl sulfone-functionalized dextran with thiol-containing crosslinkers. This composite material approach creates a more stable hydrogel network that maintains structural integrity longer than single-chemistry systems, enabling sustained cell culture while preserving encapsulation functionality.
2Manufacturing precision
If standard hydrogel microbead methods are used, then cell encapsulation is achieved, but manufacturing precision deteriorates due to cell settling and aggregation
Solution Approach 1:
The patent applies preliminary stabilization measures by using vinyl sulfone-thiol crosslinking chemistry that forms stable bonds before cell settling can occur. This preliminary chemical stabilization prevents the aggregation and uneven distribution problems that plague standard hydrogel microbead methods, ensuring uniform cell encapsulation from the outset.
Solution Approach 2:
The patent employs a crosslinking chemistry system that is inherently stable and does not require additional stabilization steps or disposable components. The vinyl sulfone-thiol system provides built-in stability that eliminates the need for secondary measures to prevent cell settling and aggregation, simplifying the manufacturing process while maintaining precision.
3Productivity
If rapid crosslinking is used to prevent cell settling, then manufacturing speed improves, but biocompatibility deteriorates due to harsh polymerization conditions
Solution Approach 1:
The patent changes the reaction kinetics parameters by using vinyl sulfone-thiol chemistry, which proceeds at an optimal speed that balances rapid crosslinking with gentle conditions. This parameter optimization allows fast bead production without exposing cells to harsh polymerization environments, maintaining both productivity and cell viability.
Solution Approach 2:
The vinyl sulfone-thiol crosslinking system acts as an intermediary that mediates between the conflicting requirements of rapid crosslinking and biocompatibility. The chemistry provides a intermediate reaction rate and mild conditions that protect cells during polymerization while still achieving sufficient crosslinking speed for practical bead production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method produces hydrogel microbeads that are biocompatible, stable, and suitable for standard laboratory manipulations, supporting prolonged cell proliferation, protein diffusion, and high-throughput drug screening, with controlled size and mechanical properties for versatile biological and medical applications.
Implementation Method 1
To bond the polymer and the linker together, different chemistries have already been proposed, such as Thiol/VS (vinyl sulfone), Maleimide/Thiol, Methacry late/Methacrylate, etc.
Implementation Method 2
Disclosed herein are methods for preparing cell encapsulated modified dextran hydrogel microparticles
Data Source
AI summary
The present invention relates to the use of modified dextran hydrogel microparticles comprising (i) at least one vinyl sulfone functionalized dextran, and (ii) at least one crosslinkable polymer having at least two thiol functions, wherein the dextran has a molecular weight comprised between 5 and 500 kDa, and the substitution degree of the dextran by the vinyl sulfone is comprised between 5 and 60%, for encapsulating at least one synthetic or natural cell. The present invention also relates to modified dextran hydrogel microparticles, a process for preparing them, an in vitro method for cultivating at least one cell comprised in said microparticles, in vitro methods for screening, for producing or for testing compounds, a kit, a microfluidic or millifluidic channel, a process for encapsulating said microparticles, and a method for the quality control of a batch. Said microparticles are useful in the field of biological and medical applications.